TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program

Jeanne M. McCaffery, Kathleen A. Jablonski, Paul W. Franks, Samuel Dagogo-Jack, Rena R. Wing, William C. Knowler, Linda Delahanty, Dana Dabelea, Richard Hamman, Alan R. Shuldiner, Jose C. Florez

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Aims: TCF7L2 variants have been associated with type 2 diabetes, body mass index (BMI), and deficits in proinsulin processing and insulin secretion. Here we sought to test whether these effects were apparent in high-risk individuals and modify treatment responses. Methods: We examined the potential role of the TCF7L2 rs7903146 variant in predicting resistance to weight loss or a lack of improvement of proinsulin processing during 2.5-years of follow-up participants (N = 2,994) from the Diabetes Prevention Program (DPP), a randomized controlled trial designed to prevent or delay diabetes in high-risk adults. Results: We observed no difference in the degree of weight loss by rs7903146 genotypes. However, the T allele (conferring higher risk of diabetes) at rs7903146 was associated with higher fasting proinsulin at baseline (P<0.001), higher baseline proinsulin:insulin ratio (p<0.0001) and increased proinsulin:insulin ratio over a median of 2.5 years of follow-up (P = 0.003). Effects were comparable across treatment arms. Conclusions: The combination of a lack of impact of the TCF7L2 genotypes on the ability to lose weight, but the presence of a consistent effect on the proinsulin:insulin ratio over the course of DPP, suggests that high-risk genotype carriers at this locus can successfully lose weight to counter diabetes risk despite persistent deficits in insulin production.

Original languageEnglish (US)
Article numbere21518
JournalPloS one
Volume6
Issue number7
DOIs
StatePublished - Aug 1 2011

Fingerprint

proinsulin
Proinsulin
Medical problems
Polymorphism
diabetes
Weight Loss
insulin
weight loss
genetic polymorphism
Insulin
Genotype
genotype
Weights and Measures
Aptitude
insulin secretion
Processing
noninsulin-dependent diabetes mellitus
Type 2 Diabetes Mellitus
fasting
body mass index

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

McCaffery, J. M., Jablonski, K. A., Franks, P. W., Dagogo-Jack, S., Wing, R. R., Knowler, W. C., ... Florez, J. C. (2011). TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program. PloS one, 6(7), [e21518]. https://doi.org/10.1371/journal.pone.0021518

TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program. / McCaffery, Jeanne M.; Jablonski, Kathleen A.; Franks, Paul W.; Dagogo-Jack, Samuel; Wing, Rena R.; Knowler, William C.; Delahanty, Linda; Dabelea, Dana; Hamman, Richard; Shuldiner, Alan R.; Florez, Jose C.

In: PloS one, Vol. 6, No. 7, e21518, 01.08.2011.

Research output: Contribution to journalArticle

McCaffery, JM, Jablonski, KA, Franks, PW, Dagogo-Jack, S, Wing, RR, Knowler, WC, Delahanty, L, Dabelea, D, Hamman, R, Shuldiner, AR & Florez, JC 2011, 'TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program', PloS one, vol. 6, no. 7, e21518. https://doi.org/10.1371/journal.pone.0021518
McCaffery, Jeanne M. ; Jablonski, Kathleen A. ; Franks, Paul W. ; Dagogo-Jack, Samuel ; Wing, Rena R. ; Knowler, William C. ; Delahanty, Linda ; Dabelea, Dana ; Hamman, Richard ; Shuldiner, Alan R. ; Florez, Jose C. / TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program. In: PloS one. 2011 ; Vol. 6, No. 7.
@article{34cdf27ba4a94415bee73343bbbbd545,
title = "TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program",
abstract = "Aims: TCF7L2 variants have been associated with type 2 diabetes, body mass index (BMI), and deficits in proinsulin processing and insulin secretion. Here we sought to test whether these effects were apparent in high-risk individuals and modify treatment responses. Methods: We examined the potential role of the TCF7L2 rs7903146 variant in predicting resistance to weight loss or a lack of improvement of proinsulin processing during 2.5-years of follow-up participants (N = 2,994) from the Diabetes Prevention Program (DPP), a randomized controlled trial designed to prevent or delay diabetes in high-risk adults. Results: We observed no difference in the degree of weight loss by rs7903146 genotypes. However, the T allele (conferring higher risk of diabetes) at rs7903146 was associated with higher fasting proinsulin at baseline (P<0.001), higher baseline proinsulin:insulin ratio (p<0.0001) and increased proinsulin:insulin ratio over a median of 2.5 years of follow-up (P = 0.003). Effects were comparable across treatment arms. Conclusions: The combination of a lack of impact of the TCF7L2 genotypes on the ability to lose weight, but the presence of a consistent effect on the proinsulin:insulin ratio over the course of DPP, suggests that high-risk genotype carriers at this locus can successfully lose weight to counter diabetes risk despite persistent deficits in insulin production.",
author = "McCaffery, {Jeanne M.} and Jablonski, {Kathleen A.} and Franks, {Paul W.} and Samuel Dagogo-Jack and Wing, {Rena R.} and Knowler, {William C.} and Linda Delahanty and Dana Dabelea and Richard Hamman and Shuldiner, {Alan R.} and Florez, {Jose C.}",
year = "2011",
month = "8",
day = "1",
doi = "10.1371/journal.pone.0021518",
language = "English (US)",
volume = "6",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program

AU - McCaffery, Jeanne M.

AU - Jablonski, Kathleen A.

AU - Franks, Paul W.

AU - Dagogo-Jack, Samuel

AU - Wing, Rena R.

AU - Knowler, William C.

AU - Delahanty, Linda

AU - Dabelea, Dana

AU - Hamman, Richard

AU - Shuldiner, Alan R.

AU - Florez, Jose C.

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Aims: TCF7L2 variants have been associated with type 2 diabetes, body mass index (BMI), and deficits in proinsulin processing and insulin secretion. Here we sought to test whether these effects were apparent in high-risk individuals and modify treatment responses. Methods: We examined the potential role of the TCF7L2 rs7903146 variant in predicting resistance to weight loss or a lack of improvement of proinsulin processing during 2.5-years of follow-up participants (N = 2,994) from the Diabetes Prevention Program (DPP), a randomized controlled trial designed to prevent or delay diabetes in high-risk adults. Results: We observed no difference in the degree of weight loss by rs7903146 genotypes. However, the T allele (conferring higher risk of diabetes) at rs7903146 was associated with higher fasting proinsulin at baseline (P<0.001), higher baseline proinsulin:insulin ratio (p<0.0001) and increased proinsulin:insulin ratio over a median of 2.5 years of follow-up (P = 0.003). Effects were comparable across treatment arms. Conclusions: The combination of a lack of impact of the TCF7L2 genotypes on the ability to lose weight, but the presence of a consistent effect on the proinsulin:insulin ratio over the course of DPP, suggests that high-risk genotype carriers at this locus can successfully lose weight to counter diabetes risk despite persistent deficits in insulin production.

AB - Aims: TCF7L2 variants have been associated with type 2 diabetes, body mass index (BMI), and deficits in proinsulin processing and insulin secretion. Here we sought to test whether these effects were apparent in high-risk individuals and modify treatment responses. Methods: We examined the potential role of the TCF7L2 rs7903146 variant in predicting resistance to weight loss or a lack of improvement of proinsulin processing during 2.5-years of follow-up participants (N = 2,994) from the Diabetes Prevention Program (DPP), a randomized controlled trial designed to prevent or delay diabetes in high-risk adults. Results: We observed no difference in the degree of weight loss by rs7903146 genotypes. However, the T allele (conferring higher risk of diabetes) at rs7903146 was associated with higher fasting proinsulin at baseline (P<0.001), higher baseline proinsulin:insulin ratio (p<0.0001) and increased proinsulin:insulin ratio over a median of 2.5 years of follow-up (P = 0.003). Effects were comparable across treatment arms. Conclusions: The combination of a lack of impact of the TCF7L2 genotypes on the ability to lose weight, but the presence of a consistent effect on the proinsulin:insulin ratio over the course of DPP, suggests that high-risk genotype carriers at this locus can successfully lose weight to counter diabetes risk despite persistent deficits in insulin production.

UR - http://www.scopus.com/inward/record.url?scp=79960780846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960780846&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0021518

DO - 10.1371/journal.pone.0021518

M3 - Article

VL - 6

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e21518

ER -